Tag: Cann Group Limited
Cann Group expects record revenue growth of 111% in FY23
Pharmaceutical company Cann Group Limited announced its FY23 unaudited results, with its operating revenue expected to be approximately $13.5 million, representing growth of 111 per cent or 2.1 times compared to the prior year revenue.
Cann granted GMP manufacturing licence for Mildura facility
The Therapeutic Goods Administration (TGA) has granted Cann Group Limited a GMP licence to manufacture therapeutic goods, which includes GMP testing at its Mildura facility.
Cann...
Cann Group supplies medicinal cannabis for Australian clinical trial for advanced cancer patients
Cann Group Limited is supplying medicinal cannabis for Australian clinical trial assessing quality of life impacts for advanced cancer patients.
The trial, which is being...
Featured Article
APS Industrial expands regional footprint with Control Technologies acquisition
APS Industrial (APS) is expanding its regional presence through the acquisition of Albury-based Control Technologies, a move the industrial products supplier said will strengthen its local service capability and support further investment in warehousing, stockholding and technical support.
